Treatments for smoking

How is smoking related to schizophrenia?

Tobacco smoking is very common among people with schizophrenia, who often show particularly heavy usage. This poses considerable health risks, may interfere with antipsychotic medications and may place a financial burden on the individual. Heavy cigarette use may contribute to the increased mortality and reduced life expectancy reported within the schizophrenia population.

What is the evidence for interventions for smoking?

Moderate to high quality evidence finds a medium-sized effect of more smoking cessation with bupropion than with placebo, which was maintained at 6 months follow-up.

Moderate to high quality evidence finds varenicline results in fewer number of cigarettes smoked per day. Moderate quality evidence also suggests varenicline results in more abstaining smoking behaviour, although total cessation rates were no different to placebo.

July 2019

Last updated at: 4:02 am, 9th July 2019
To view documentation related to this topic download the files below
Fact Sheet Technical Commentary

NeuRA Libraries

Title Colour Legend:
Green - Topic summary is available.
Orange - Topic summary is being compiled.
Red - Topic summary has no current systematic review available.